TABLE 1.

Technical performance and outcomes endpoints after transapical transcatheter aortic valve replacement

Endpoint	n*	n (%)
Technical performance
Procedure time, min	1092	120.0 ± 66.7†
Fluoroscopy time, min	1048	13.5 ± 10.5†
Contrast medium, mL	1057	45/90/150‡
Postdilatations	1096
0		980 (89)
1		103 (9.4)
2		12 (1.1)
3		1 (0.09)
Outcomes
Device success	1061	930 (88)
Aortic regurgitation grade at discharge
Total	1021
None/trace		587 (57)
Mild		366 (36)
Moderate		64 (6.3)
Severe		4 (0.39)
Transvalvular	1020
None/trace		907 (89)
Mild		109 (11)
Moderate		4 (0.39)
Severe		0 (0)
Paravalvular	1018
None/trace		657 (65)
Mild		305 (30)
Moderate		53 (5.2)
Severe		3 (0.29)
Adverse events during procedure	1100	257 (23)
Myocardial perforation	1100	11 (1.0)
Ventricular injury	1100	4 (0.36)
Adverse events within 30 d	1100
Stroke		29 (2.6)
Mortality		96 (8.7)
Major bleeding		97 (8.8)
Major vascular complication		39 (3.5)
Composite 30-d major adverse event	1100	354 (32)
Postprocedure length of stay, d	1081	5/8/15‡

^*Patients with data available.

^†Mean ± standard deviation.

^‡15th/50th/85th percentiles.